Harvard Bioscience
HBIO
HBIO
85 hedge funds and large institutions have $79.2M invested in Harvard Bioscience in 2020 Q3 according to their latest regulatory filings, with 7 funds opening new positions, 27 increasing their positions, 36 reducing their positions, and 9 closing their positions.
New
Increased
Maintained
Reduced
Closed
less capital invested
Capital invested by funds: $ → $
less ownership
Funds ownership: →
less funds holding
Funds holding: →
less first-time investments, than exits
New positions opened: | Existing positions closed:
25% less repeat investments, than reductions
Existing positions increased: 27 | Existing positions reduced: 36
100% less funds holding in top 10
Funds holding in top 10: 1 → 0 (-1)
Holders
85
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$1.57M | |
| 2 | +$1.2M | |
| 3 | +$783K | |
| 4 |
Renaissance Technologies
New York
|
+$660K |
| 5 |
EIM
Essex Investment Management
Boston,
Massachusetts
|
+$438K |
Top Sellers
| 1 | -$2.25M | |
| 2 | -$1.08M | |
| 3 | -$845K | |
| 4 |
Assenagon Asset Management
Senningerberg,
Luxembourg
|
-$725K |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
-$365K |